Mettler-Toledo International, Inc. (MTD) vs Natera, Inc. (NTRA)

Mettler-Toledo International, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $59.2B against $30.4B — 1.9× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Mettler-Toledo International, Inc. trades at 33.9×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs −7.11%) and the higher return on invested capital (35.4% vs −22.3%). Across the 20 metrics below, Mettler-Toledo International, Inc. leads on 13 and Natera, Inc. on 7.

Valuation

Metric MTD NTRA Diagnostics & Research median
P/E 33.94 n/m 33.95
P/S 7.36 21.84 4.87
P/B 2,372.01 32.45 3.12
Price to free cash flow 35.21 702.06 34.02
EV/EBITDA 24.88 n/m 25.20
EV/Sales 7.86 21.57 5.66
Earnings yield 2.95% (0.33%) (1.75%)
Free cash flow yield 2.84% 0.14% (0.13%)

Profitability

Metric MTD NTRA Diagnostics & Research median
Gross margin 60.26% 65.23% 50.89%
Operating margin 28.41% (10.70%) (8.57%)
Net margin 21.91% (7.11%) (6.37%)
Free cash flow margin 20.90% 3.11% 0.00%
Return on equity (736.36%) (12.54%) (2.92%)
Return on assets 25.61% (8.71%) (6.71%)
Return on invested capital 35.40% (22.34%) 0.00%

Growth

Metric MTD NTRA Diagnostics & Research median
Revenue growth (TTM) 6.91% 37.82% 7.69%
EPS growth (last fiscal year) 3.88% 0.65% —
Revenue growth, 5-year CAGR 5.47% 42.61% 7.40%
Net income growth, 5-year CAGR 7.60% 0.00% 0.00%

Health

Metric MTD NTRA Diagnostics & Research median
Debt to equity 164.70 0.04 0.11
Current ratio 1.12 3.00 2.02
Net debt to EBITDA 1.68 3.74 0.78

Dividend

Metric MTD NTRA Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MTD NTRA Diagnostics & Research median
Market cap 30.44b 59.17b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack